Saxagliptin, Metformin Combination Tablets Approved for Type 2 Diabetes
Links shared publicly online about this topic
FDA approves metformin/saxagliptin combination for type 2 diabetes
endocrinetoday.com — “The once-daily metformin extended-release plus dipeptidyl peptidase-4 tablet demonstrated significant reductions in HbA1c levels, fasting plasma” View full resource at endocrinetoday.com
Most Recently Shared on November 8, 2010 at 4:36 pm By:
#FDA approves metformin/saxagliptin combination for type 2 diabetes http://bit.ly/aJUY00
Kombiglyze XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults
drugs.com — “Kombiglyze XR (saxagliptin and metformin) is used to treat type 2 diabetes. Includes Kombiglyze XR side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 7, 2010 at 9:55 pm By:
FDA Approves Kombiglyze XR (saxagliptin and metformin) for the Treatment of Type 2 Diabetes Mellitus - http://bit.ly/bGBTlz
Kombiglyze XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults
drugs.com — “Kombiglyze XR (saxagliptin and metformin) is used to treat type 2 diabetes. Includes Kombiglyze XR side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 7, 2010 at 10:13 pm By:
Drugs and Devices OW OW Health
Kombiglyze XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatm... http://bit.ly/blx4wx #drug
Kombiglyze™ Xr (Saxagliptin And Metformin Hcl Extended-Release) Tablets Approved In The U.S. For The Treatment Of Type 2 Diabetes Mellitus In Ad
medicalnewstoday.com — “Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE™ XR for the treatment of type 2 diabetes i” View full resource at medicalnewstoday.com
Most Recently Shared on November 8, 2010 at 6:05 pm By:
Kombiglyze™ Xr (Saxagliptin And Metformin Hcl Extended-Release) Tablets Approved In The U.S. For The Treatment O... http://mnt.to/3Mcv
KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release) tablets approved in the U.S. for the treatment of type 2 diabetes mellitus in adults
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on November 5, 2010 at 5:21 pm By:
eyeonfda Pharma and Health Lawyer
AZ sez FDA approves KOMBIGLYZEâ„¢ XR (saxagliptin and metformin HCl extended-release) tablets for type 2 adult diabetes http://ow.ly/357wz
KOMBIGLYZE" XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults
businesswire.com — “Bristol-Myers Squibb and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE™ XR for the treatment” View full resource at businesswire.com
Most Recently Shared on November 6, 2010 at 5:28 pm By:
KOMBIGLYZEâ„¢ XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. (BioSpace) http://bit.ly/c9ijsw
KOMBIGLYZE XR (Saxagliptin and Metformin HCl Extended-Release) Tablets, a New Treatment for Type 2 Diabetes Mellitus in Adults, Now Available in U.S. Pharmacies - Drugs.com MedNews
drugs.com — “The first and only once-a-day metformin extended-release (XR) plus DPP-4 inhibitor combination tablet Jan 7, 2011 - Bristol-Myers Squibb Company (NYSE BMY), and” View full resource at drugs.com
Most Recently Shared on January 8, 2011 at 6:07 am By:
Drugs and Devices OW OW Health
KOMBIGLYZE XR (Saxagliptin and Metformin HCl Extended-Release) Tablets, a New Treatment for Type 2 Diabete... http://bit.ly/epdTOV #drug
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes
news-medical.net — “Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycaemic) control in adult patients with type 2 diabetes.” View full resource at news-medical.net
Most Recently Shared on November 28, 2011 at 3:53 pm By:
Diabetes News: European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes: Bri... http://t.co/IjDwRuPp
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes
news-medical.net — “Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycaemic) control in adult patients with type 2 diabetes.” View full resource at news-medical.net
Most Recently Shared on November 28, 2011 at 5:30 pm By:
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes: Bristol-Myers Squi... http://t.co/mO9KYHaO
Kombiglyze XR tablets approved for the treatment of type 2 diabetes mellitus in adults - - Drug Topics
drugtopics.modernmedicine.com — “FDA has approved saxagliptin and metformin extended-release (XR) (Kombiglyze XR, AstraZeneca/Bristol-Myers Squibb) tablets for the treatment of type 2 diabetes in adults. Kombiglyze XR is the first and only once-a-day metformin XR plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet offering strong glycemic control across glycosylated hemoglobin levels, fasting plasma glucose, and postprandial glucose.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on November 12, 2010 at 2:02 pm By:
Kombiglyze XR tablets approved for the treatment of type 2 diabetes mellitus in adults: FDA has approved saxagli... http://bit.ly/cIZrir
FDA approves extended-release tablets for type 2 diabetes - - Drug Topics
drugtopics.modernmedicine.com — “FDA approved sitagliptin and metformin hydrochloride (HCl) extended-release (Janumet XR, Merck) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of Januvia (sitagliptin), with extended-release metformin.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on February 6, 2012 at 2:13 am By:
FDA approves extended-release tablets for type 2 diabetes: FDA approved sitagliptin and metformin hydrochloride ... http://t.co/5Kio7lsL
Kombiglyze XR Approved for Adult Type 2 Diabetes - Drugs.com MedNews
drugs.com — “The combination drug Kombiglyze (saxagliptin, metformin XR) has been approved by the U.S. Food and Drug Administration to help control blood sugar in adults wit” View full resource at drugs.com
Most Recently Shared on November 5, 2010 at 9:08 pm By:
Drugs and Devices OW OW Health
Kombiglyze XR Approved for Adult Type 2 Diabetes: FRIDAY, Nov. 5 -- The combination drug Kombiglyze (saxag... http://bit.ly/asygVn #drug
KOMBIGLYZE™ XR Tablets Approved In The US For The Treatment Of Type 2 Diabetes Mellitus In Adults
medicalnewstoday.com — “AstraZeneca and Bristol-Myers Squibb Company announced that the US Food and Drug Administration (FDA) approved KOMBIGLYZE™ XR for the treatment of type 2 diabetes in adults. KOMBIGLYZE XR i” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 4:05 pm By:
KOMBIGLYZE™ XR Tablets Approved In The US For The Treatment Of Type 2 Diabetes Mellitus In Adults http://mnt.to/3Mm3 #diabetes
Kombiglyze XR Approved for Adult Type 2 Diabetes - Diabetes Mellitus, Type 2 Diabetes, Type 1, and Metabolic Disorders Treatment and Medications on MedicineNet.com
medicinenet.com — “Medical information about Diabetes Mellitus, Type 2, Type 1, and Metabolic Disorders treatment and medications.” View full resource at medicinenet.com
Most Recently Shared on November 9, 2010 at 7:51 am By:
Kombiglyze XR Approved for Adult Type 2 Diabetes: Title: Kombiglyze XR Approved for Adult Type 2 Diabetes Catego... http://bit.ly/cBXYUf
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes
news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.” View full resource at news-medical.net
Most Recently Shared on January 31, 2012 at 12:29 pm By:
Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes: Boehringer Ingelheim P... http://t.co/QrEPkXXO
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
